Trial of Cystectomy Alone Versus Neoadjuvant M-VAC +Cystectomy in Patients with Locally Advanced Bladder Cancer
Research committees
Treatment
Publication Information Expand/Collapse
2021
2020
Economic evaluations in NCI-sponsored network cancer clinical trials
PMid: PMID33248521 | PMC number: PMC8262264
PMid: PMID32352530 | PMC number: PMC7193331
2017
PMid: PMID28586789; PMC5710507
2016
PMid: PMID27020106 | PMC number: PMC5126649
PMid: PMID27787873 | PMC number: PMC5319875
2014
Comparison of survival outcomes among cancer patients treated in and out of clinical trials
PMid: PMID24627276 | PMC number: PMC3982777
2013
2011
Do mixed histologic features affect survival benefit from neo-adjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer treated with radical cystectomy? A secondary analysis of Southwest Oncology Group-directed intergroup study (S8710) [PMID 21105991; PMC3117124
2010
Do mixed histologic features affect survival benefit from neo-adjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
Do mixed histologic features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
2009
Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant MVAC
Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant chemotherapy. 2009 [PMID19517476; PMC3079554]
2008
The Southwest Oncology Group: progress in cancer research [PMID18929152]
2005
Optimal combined modality treatment improves outcome of locally advanced bladder cancer: analyis of SWOG 8710
2004
Surgical factors influence bladder cancer outcomes: a Cooperative Group report
Pathologic evaluation of radical cystectomy specimens: a Cooperative Group report
2003
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
Surgical variables impact bladder cancer outcomes: a cooperative group report.
Southwest Oncology Group studies in bladder cancer
2001
SWOG 8710 (INT-0080): randomized phase III trial of neoadjuvant MVAC + cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
SWOG 8710 (INT-0080): randomized phase III trial of neoadjuvant MVAC + cystectomy versus cystectomy alone in patients with locally advanced bladder cancer